source
- Radiopharmaceutical experts urge pharma to adopt bolder dosing despite safety concernsLouise Emmett and a group of radiopharmaceutical specialists argue that these modern radiation‑based drugs could dramatically improve cancer outcomes if used more aggressively. They say the therapi…
- Natera partners with Angiex to evaluate Signatera blood test in AGX101 cancer trialNatera announced a collaboration with biotech Angiex to assess its Signatera circulating tumor DNA blood test in the context of Angiex’s early‑stage clinical trial of AGX101. Angiex, based in Camb…